<!DOCTYPE html>
<html>
<head>
<meta http-equiv="X-UA-Compatible" content="IE=Edge" />
<meta charset="utf-8" />
</head>

<body style="margin: 0;">

<div id="p68" style="overflow: hidden; position: relative; background-color: white; width: 1210px; height: 935px;">
<style class="shared-css" type="text/css" >
.t {
	transform-origin: bottom left;
	z-index: 2;
	position: absolute;
	white-space: pre;
	overflow: visible;
	line-height: 1.5;
}
.text-container {
	white-space: pre;
}
@supports (-webkit-touch-callout: none) {
	.text-container {
		white-space: normal;
	}
}
</style>
<style type="text/css" >

#t1_68{left:36px;bottom:25px;letter-spacing:0.07px;word-spacing:0.01px;}
#t2_68{left:341px;bottom:30px;}
#t3_68{left:348px;bottom:25px;letter-spacing:0.11px;}
#t4_68{left:377px;bottom:30px;}
#t5_68{left:381px;bottom:25px;letter-spacing:0.07px;word-spacing:-0.1px;}
#t6_68{left:540px;bottom:30px;}
#t7_68{left:546px;bottom:25px;letter-spacing:0.07px;}
#t8_68{left:44px;bottom:77px;letter-spacing:0.1px;word-spacing:-0.05px;}
#t9_68{left:44px;bottom:63px;letter-spacing:0.1px;}
#ta_68{left:285px;bottom:860px;letter-spacing:-0.32px;word-spacing:0.06px;}
#tb_68{left:285px;bottom:827px;letter-spacing:-0.32px;word-spacing:-0.15px;}
#tc_68{left:996px;bottom:873px;letter-spacing:-0.1px;}
#td_68{left:1043px;bottom:853px;letter-spacing:-0.22px;word-spacing:0.13px;}
#te_68{left:1093px;bottom:833px;letter-spacing:-0.09px;}
#tf_68{left:1123px;bottom:28px;letter-spacing:0.02px;}
#tg_68{left:36px;bottom:148px;}
#th_68{left:46px;bottom:142px;letter-spacing:0.12px;word-spacing:-0.03px;}
#ti_68{left:556px;bottom:142px;}
#tj_68{left:36px;bottom:131px;}
#tk_68{left:46px;bottom:125px;letter-spacing:0.1px;word-spacing:-0.04px;}
#tl_68{left:318px;bottom:125px;}
#tm_68{left:36px;bottom:114px;}
#tn_68{left:46px;bottom:108px;letter-spacing:0.13px;}
#to_68{left:261px;bottom:108px;}
#tp_68{left:36px;bottom:778px;letter-spacing:0.46px;}
#tq_68{left:649px;bottom:778px;letter-spacing:0.36px;word-spacing:-0.32px;}
#tr_68{left:1043px;bottom:778px;letter-spacing:0.47px;}
#ts_68{left:1043px;bottom:760px;letter-spacing:0.44px;word-spacing:-0.26px;}
#tt_68{left:1043px;bottom:742px;letter-spacing:0.45px;}
#tu_68{left:36px;bottom:476px;letter-spacing:-0.09px;}
#tv_68{left:36px;bottom:458px;letter-spacing:-0.08px;}
#tw_68{left:36px;bottom:440px;letter-spacing:-0.1px;}
#tx_68{left:218px;bottom:616px;letter-spacing:-0.08px;}
#ty_68{left:218px;bottom:293px;letter-spacing:-0.1px;}
#tz_68{left:218px;bottom:513px;letter-spacing:-0.09px;}
#t10_68{left:218px;bottom:495px;letter-spacing:-0.09px;}
#t11_68{left:218px;bottom:476px;letter-spacing:-0.09px;}
#t12_68{left:218px;bottom:458px;letter-spacing:-0.09px;}
#t13_68{left:218px;bottom:440px;letter-spacing:-0.09px;}
#t14_68{left:218px;bottom:421px;letter-spacing:-0.26px;word-spacing:0.18px;}
#t15_68{left:218px;bottom:403px;letter-spacing:-0.09px;}
#t16_68{left:537px;bottom:612px;letter-spacing:-0.11px;}
#t17_68{left:537px;bottom:384px;letter-spacing:-0.11px;}
#t18_68{left:537px;bottom:222px;letter-spacing:-0.11px;}
#t19_68{left:648px;bottom:676px;letter-spacing:-0.1px;}
#t1a_68{left:893px;bottom:684px;}
#t1b_68{left:648px;bottom:658px;letter-spacing:-0.1px;}
#t1c_68{left:648px;bottom:639px;letter-spacing:-0.1px;}
#t1d_68{left:891px;bottom:647px;}
#t1e_68{left:648px;bottom:621px;letter-spacing:-0.1px;}
#t1f_68{left:648px;bottom:603px;letter-spacing:-0.1px;}
#t1g_68{left:712px;bottom:610px;}
#t1h_68{left:725px;bottom:603px;letter-spacing:-0.1px;}
#t1i_68{left:769px;bottom:610px;}
#t1j_68{left:782px;bottom:603px;letter-spacing:-0.1px;}
#t1k_68{left:968px;bottom:610px;letter-spacing:-0.12px;}
#t1l_68{left:648px;bottom:584px;letter-spacing:-0.09px;}
#t1m_68{left:648px;bottom:566px;letter-spacing:-0.06px;}
#t1n_68{left:648px;bottom:548px;letter-spacing:-0.1px;}
#t1o_68{left:648px;bottom:439px;letter-spacing:-0.1px;}
#t1p_68{left:891px;bottom:446px;}
#t1q_68{left:648px;bottom:421px;letter-spacing:-0.06px;}
#t1r_68{left:648px;bottom:402px;letter-spacing:-0.1px;}
#t1s_68{left:648px;bottom:384px;}
#t1t_68{left:648px;bottom:366px;letter-spacing:-0.08px;}
#t1u_68{left:648px;bottom:347px;letter-spacing:-0.06px;}
#t1v_68{left:648px;bottom:329px;letter-spacing:-0.08px;}
#t1w_68{left:1049px;bottom:704px;letter-spacing:-0.09px;}
#t1x_68{left:1049px;bottom:685px;letter-spacing:-0.27px;}
#t1y_68{left:1113px;bottom:693px;}
#t1z_68{left:1049px;bottom:667px;letter-spacing:-0.07px;}
#t20_68{left:1049px;bottom:649px;letter-spacing:-0.09px;}
#t21_68{left:1049px;bottom:630px;letter-spacing:-0.1px;}
#t22_68{left:1049px;bottom:612px;letter-spacing:-0.08px;}
#t23_68{left:1049px;bottom:594px;letter-spacing:-0.13px;}
#t24_68{left:1049px;bottom:575px;letter-spacing:-0.1px;}
#t25_68{left:1049px;bottom:557px;letter-spacing:-0.08px;}
#t26_68{left:1049px;bottom:539px;letter-spacing:-0.09px;}
#t27_68{left:1049px;bottom:520px;letter-spacing:-0.1px;}
#t28_68{left:1049px;bottom:476px;letter-spacing:-0.08px;}
#t29_68{left:1049px;bottom:458px;letter-spacing:-0.09px;}
#t2a_68{left:1049px;bottom:440px;letter-spacing:-0.08px;}
#t2b_68{left:1049px;bottom:421px;letter-spacing:-0.06px;}
#t2c_68{left:1049px;bottom:403px;letter-spacing:-0.08px;}
#t2d_68{left:1049px;bottom:385px;letter-spacing:-0.09px;}
#t2e_68{left:1049px;bottom:366px;letter-spacing:-0.09px;}
#t2f_68{left:1049px;bottom:348px;letter-spacing:-0.09px;}
#t2g_68{left:1049px;bottom:330px;letter-spacing:-0.1px;}
#t2h_68{left:1109px;bottom:337px;}
#t2i_68{left:1049px;bottom:311px;letter-spacing:-0.1px;}
#t2j_68{left:1049px;bottom:293px;letter-spacing:-0.08px;}
#t2k_68{left:1049px;bottom:275px;letter-spacing:-0.13px;}
#t2l_68{left:648px;bottom:277px;letter-spacing:-0.1px;}
#t2m_68{left:891px;bottom:284px;}
#t2n_68{left:648px;bottom:258px;letter-spacing:-0.1px;}
#t2o_68{left:648px;bottom:240px;letter-spacing:-0.1px;}
#t2p_68{left:648px;bottom:222px;}
#t2q_68{left:648px;bottom:203px;letter-spacing:-0.08px;}
#t2r_68{left:648px;bottom:185px;letter-spacing:-0.06px;}
#t2s_68{left:648px;bottom:167px;letter-spacing:-0.09px;}
#t2t_68{left:23px;bottom:915px;letter-spacing:-0.14px;}

.s0_68{font-size:9px;font-family:ArialMT_5tg;color:#000;}
.s1_68{font-size:5px;font-family:ArialMT_5tg;color:#000;}
.s2_68{font-size:12px;font-family:Arial-BoldMT_5te;color:#000;}
.s3_68{font-size:28px;font-family:Arial-BoldMT_5te;color:#000;}
.s4_68{font-size:17px;font-family:ArialMT_5tg;color:#0065A4;}
.s5_68{font-size:17px;font-family:Arial-BoldMT_5te;color:#000;}
.s6_68{font-size:12px;font-family:ArialMT_5tg;color:#000;}
.s7_68{font-size:15px;font-family:ArialMT_5tg;color:#0065A4;}
.s8_68{font-size:15px;font-family:ArialMT_5tg;color:#000;}
.s9_68{font-size:17px;font-family:Arial-BoldMT_5te;color:#0065A4;}
.sa_68{font-size:14px;font-family:Arial-BoldMT_5te;color:#000;}
.sb_68{font-size:11px;font-family:Helvetica, Arial, sans-serif;color:#000;}
</style>
<style id="fonts68" type="text/css" >

@font-face {
	font-family: Arial-BoldMT_5te;
	src: url("fonts/Arial-BoldMT_5te.woff") format("woff");
}

@font-face {
	font-family: ArialMT_5tg;
	src: url("fonts/ArialMT_5tg.woff") format("woff");
}

</style>
<div id="pg68Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg68" style="-webkit-user-select: none;"><object width="1210" height="935" data="68/68.svg" type="image/svg+xml" id="pdf68" style="width:1210px; height:935px; z-index: 0;"></object></div>
<div class="text-container"><span id="t1_68" class="t s0_68">Version 4.2024, 5/1/2024 © 2024 National Comprehensive Cancer Network </span>
<span id="t2_68" class="t s1_68">® </span>
<span id="t3_68" class="t s0_68">(NCCN </span>
<span id="t4_68" class="t s1_68">® </span>
<span id="t5_68" class="t s0_68">), All rights reserved. NCCN Guidelines </span>
<span id="t6_68" class="t s1_68">® </span>
<span id="t7_68" class="t s0_68">and this illustration may not be reproduced in any form without the express written permission of NCCN. </span>
<span id="t8_68" class="t s2_68">Note: All recommendations are category 2A unless otherwise indicated. </span>
<span id="t9_68" class="t s2_68">Clinical Trials: NCCN believes that the best management of any patient with cancer is in a clinical trial. Participation in clinical trials is especially encouraged. </span>
<span id="ta_68" class="t s3_68">NCCN Guidelines Version 4.2024 </span>
<span id="tb_68" class="t s3_68">Very Advanced Head and Neck Cancer </span>
<span id="tc_68" class="t s4_68">NCCN Guidelines Index </span>
<span id="td_68" class="t s4_68">Table of Contents </span>
<span id="te_68" class="t s4_68">Discussion </span>
<span id="tf_68" class="t s5_68">ADV-2 </span>
<span id="tg_68" class="t s6_68">a </span>
<span id="th_68" class="t s7_68">Principles of Systemic Therapy for Non-Nasopharyngeal Cancers (SYST-A)</span><span id="ti_68" class="t s8_68">. </span>
<span id="tj_68" class="t s6_68">b </span>
<span id="tk_68" class="t s7_68">Principles of Radiation Therapy (ADV-A)</span><span id="tl_68" class="t s8_68">. </span>
<span id="tm_68" class="t s6_68">d </span>
<span id="tn_68" class="t s7_68">Principles of Surgery (SURG-A)</span><span id="to_68" class="t s8_68">. </span>
<span id="tp_68" class="t s5_68">DIAGNOSIS </span><span id="tq_68" class="t s5_68">TREATMENT OF HEAD AND NECK CANCER </span><span id="tr_68" class="t s5_68">PERSISTENT </span>
<span id="ts_68" class="t s5_68">DISEASE OR </span>
<span id="tt_68" class="t s5_68">PROGRESSION </span>
<span id="tu_68" class="t s5_68">Metastatic (M1) </span>
<span id="tv_68" class="t s5_68">disease at initial </span>
<span id="tw_68" class="t s5_68">presentation </span>
<span id="tx_68" class="t s5_68">Clinical trial preferred </span>
<span id="ty_68" class="t s5_68">Distant metastases </span>
<span id="tz_68" class="t s5_68">Consider </span>
<span id="t10_68" class="t s5_68">locoregional </span>
<span id="t11_68" class="t s5_68">treatment based </span>
<span id="t12_68" class="t s5_68">on primary site </span>
<span id="t13_68" class="t s5_68">algorithms </span>
<span id="t14_68" class="t s9_68">(Table of </span>
<span id="t15_68" class="t s9_68">Contents) </span>
<span id="t16_68" class="t s5_68">PS 0–1 </span>
<span id="t17_68" class="t s5_68">PS 2 </span>
<span id="t18_68" class="t s5_68">PS 3 </span>
<span id="t19_68" class="t s5_68">Combination systemic therapy </span>
<span id="t1a_68" class="t sa_68">a </span>
<span id="t1b_68" class="t s5_68">or </span>
<span id="t1c_68" class="t s5_68">Single-agent systemic therapy </span>
<span id="t1d_68" class="t sa_68">a </span>
<span id="t1e_68" class="t s5_68">or </span>
<span id="t1f_68" class="t s5_68">Surgery </span>
<span id="t1g_68" class="t sa_68">d </span>
<span id="t1h_68" class="t s5_68">or RT </span>
<span id="t1i_68" class="t sa_68">b </span>
<span id="t1j_68" class="t s5_68">or systemic therapy/RT </span>
<span id="t1k_68" class="t sa_68">a,b </span>
<span id="t1l_68" class="t s5_68">for selected patients with limited metastases </span>
<span id="t1m_68" class="t s5_68">or </span>
<span id="t1n_68" class="t s5_68">Best supportive care </span>
<span id="t1o_68" class="t s5_68">Single-agent systemic therapy </span>
<span id="t1p_68" class="t sa_68">a </span>
<span id="t1q_68" class="t s5_68">or </span>
<span id="t1r_68" class="t s5_68">Best supportive care </span>
<span id="t1s_68" class="t s5_68">± </span>
<span id="t1t_68" class="t s5_68">Palliative RT </span>
<span id="t1u_68" class="t s5_68">or </span>
<span id="t1v_68" class="t s5_68">Palliative surgery </span>
<span id="t1w_68" class="t s5_68">Systemic </span>
<span id="t1x_68" class="t s5_68">therapy, </span>
<span id="t1y_68" class="t sa_68">a </span>
<span id="t1z_68" class="t s5_68">clinical trial </span>
<span id="t20_68" class="t s5_68">preferred </span>
<span id="t21_68" class="t s5_68">or </span>
<span id="t22_68" class="t s5_68">Palliative </span>
<span id="t23_68" class="t s5_68">RT </span>
<span id="t24_68" class="t s5_68">or </span>
<span id="t25_68" class="t s5_68">Best </span>
<span id="t26_68" class="t s5_68">supportive </span>
<span id="t27_68" class="t s5_68">care </span>
<span id="t28_68" class="t s5_68">Best </span>
<span id="t29_68" class="t s5_68">supportive </span>
<span id="t2a_68" class="t s5_68">care </span>
<span id="t2b_68" class="t s5_68">or </span>
<span id="t2c_68" class="t s5_68">Alternate </span>
<span id="t2d_68" class="t s5_68">single- </span>
<span id="t2e_68" class="t s5_68">agent </span>
<span id="t2f_68" class="t s5_68">systemic </span>
<span id="t2g_68" class="t s5_68">therapy </span>
<span id="t2h_68" class="t sa_68">a </span>
<span id="t2i_68" class="t s5_68">or </span>
<span id="t2j_68" class="t s5_68">Palliative </span>
<span id="t2k_68" class="t s5_68">RT </span>
<span id="t2l_68" class="t s5_68">Single-agent systemic therapy </span>
<span id="t2m_68" class="t sa_68">a </span>
<span id="t2n_68" class="t s5_68">or </span>
<span id="t2o_68" class="t s5_68">Best supportive care </span>
<span id="t2p_68" class="t s5_68">± </span>
<span id="t2q_68" class="t s5_68">Palliative RT </span>
<span id="t2r_68" class="t s5_68">or </span>
<span id="t2s_68" class="t s5_68">Palliative surgery </span>
<span id="t2t_68" class="t sb_68">Printed by Fredd Merc on 8/29/2024 4:45:54 AM. For personal use only. Not approved for distribution. Copyright © 2024 National Comprehensive Cancer Network, Inc., All Rights Reserved. </span></div>

</div>
</body>
</html>
